Naropin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 63323-288
  • Package NDC 63323-288-27
  • Application number NDA020533
  • SPL ID 75465ceb-e894-487d-aa80-671fa0841fce
  • SPL set ID 56dfabf7-f7a8-4601-b17a-cb16fb995b0f
  • UNII V910P86109
  • RxCUI 1734084
  • RxCUI 1734086
  • RxCUI 1734090
  • RxCUI 1734091

What the source publishes

Labeler
Fresenius Kabi USA, LLC
Active ingredients
ROPIVACAINE HYDROCHLORIDE
Form
INJECTION, SOLUTION
Routes
EPIDURAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:63323-288_75465ceb-e894-487d-aa80-671fa0841fce
{
  "name": "Naropin",
  "splId": "75465ceb-e894-487d-aa80-671fa0841fce",
  "labels": [
    {
      "setId": "56dfabf7-f7a8-4601-b17a-cb16fb995b0f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56dfabf7-f7a8-4601-b17a-cb16fb995b0f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=56dfabf7-f7a8-4601-b17a-cb16fb995b0f"
    }
  ],
  "routes": [
    "EPIDURAL"
  ],
  "labeler": "Fresenius Kabi USA, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "5 AMPULE in 1 BOX (63323-288-27)  / 20 mL in 1 AMPULE (63323-288-25)",
      "package_ndc": "63323-288-27",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20090804"
    }
  ],
  "productId": "63323-288_75465ceb-e894-487d-aa80-671fa0841fce",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "63323-288",
  "deaSchedule": null,
  "genericName": "ROPIVACAINE HYDROCHLORIDE",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ROPIVACAINE HYDROCHLORIDE",
      "strength": "10 mg/mL"
    }
  ],
  "applicationNumber": "NDA020533",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "19960924",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "V910P86109"
    ],
    "rxcui": [
      "1734084",
      "1734086",
      "1734090",
      "1734091"
    ],
    "spl_set_id": [
      "56dfabf7-f7a8-4601-b17a-cb16fb995b0f"
    ],
    "manufacturer_name": [
      "Fresenius Kabi USA, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:63323-288_75465ceb-e894-487d-aa80-671fa0841fce"